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Background: The Vhembe region of the Limpopo province has a rich tradition of medicinal plants use. Traditionally,
boiled roots of Ziziphus mucronata are used in the treatment of boils, general swelling and other skin infections. A
combination of leaf paste and root infusion treats measles, dysentery, chest complains, and gland swelling. Pterocarpus
angolensis is famous for the treatment of menorrhagia, infertility in women, wounds and pain management. The
purpose of the present study was to compare the cytotoxicity, anti-inflammatory potential and anti-microbial activities
of Ziziphus mucronata and Pterocarpus angolensis from the Vhembe region.
Method: U937, MeWo, Vero and RAW 264.7 cells were treated to various concentrations (50, 100, or 125 or 250 μg/ml
depending on assays) of Ziziphus mucronata and Pterocarpus angolensis. Cytotoxicity assay was done using MTT; Anti-
inflammatory activity was assessed using NO production; Anti-bacterial activity was done using the Micro-Broth dilution
method and Anti-mycobacteria activity was determined using the Alamar Blue Method while RT activity was measured
by ELISA.
Results: Cytotoxicity results showed that Pterocarpus was more toxic than Ziziphus as observed in the Vero and MeWo
cells; however both displayed toxicity towards a Human cancer cell line. Both extracts did not inhibit nitrate production
but induced significant increase in macrophage activation. The plant extracts have shown anti-tuberculosis activity at
concentrations >500 μg/ml and there was moderation inhibition of HIV replication.
Conclusions: The results obtained indicated that the extracts have pro-inflammatory properties, and the observed
toxicity on malignant cell lines must be investigated further for promising anti-cancer drug therapy.
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The use of medicinal plants has been recorded for
centuries with consistency regarding their uses as well as
effectiveness in the treatment of diseases [2]. The use of
traditional medicines by traditional healers has played an
important role in the health care of millions of people.
The diversity of about 24,000 indigenous plants in South
Africa contributes an estimate of 10% of higher plants* Correspondence: muendi.sigidi@yahoo.com
1Microbiology Department, University of Venda, Private Bag X5050,
Thohoyandou, Limpopo Province, South Africa
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeon globally [24]. The majority of people in South Africa
rely heavily on the traditional use of medicinal plants
with an estimated 70% of the population using one or
more of the approximate 3000 species of plants used as
traditional medicines [24, 33, 35].
Ziziphus mucronata Willd is commonly known as buf-
falo thorn (Mukhalu), it belongs to the Rhamnaceae
family and is found in most parts of the country
[10, 29]. Traditionally, boiled roots concotions are used
in the treatment of boils, general swelling and other skin
infections. A combination of leaf paste and root infusion
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([5]; [35–37]; [14, 18]). The active ingredients are sev-
eral alkaloids known as peptide alkaloids such as
mucronine D [34].
Pterocarpus angolensis DC belongs to the family
Fabaceae, it is commonly known as bleedwood tree
(Mutondo). Bark infusions are dropped into aching ear to
neutralize the pain, boiled extract can be taken orally for
menorrhagia [19]; roots infusions are used as a remedy for
infertility amongst women [19]. Mutondo is also known
for its popular use in treatment of eye infections [19],
wounds and psoriasis [14]. The value of its timber carries
a lot of weight amongst the African cultures since it is
easy to work with for furniture, implements and curios
purposes. Mutondo is also employed in the construction
of canoes because the wood does easily shrink or swell
much. The African women mixes the red sap with fresh
animal fat to make a cosmetic for faces and bodies to en-
hance their beauty. It is also believed to have magical
properties with regards to cleansing human blood from
different ailments and spiritual possessions’; the belief is
due to the red sap close resemblance to blood.
In the current study, we evaluated the claim by trad-
itional healers of these two plants’ biological activities.
Methods
Description of plant materials
Stem Barks of Ziziphus mucronata (MPT00123) and
Pterocarpus angolensis (MPT00118) were collected in
2014 in their natural habitat in the Vhembe District of
the Limpopo Province (South Africa). The collected
plants were identified using their vernacular names and
later confirmed by the taxonomic rank at the Department
of Botany, University of Venda with reference to the inter-
national plant name index (Ziziphus mucronata Willd and
Pterocarpus angolensis DC). The samples were deposited
in the departmental herbarium.
Bark samples for each plant were air dried and ground
to fine powder using a Buchi mixer (Buchi Labortechnik
AG, Flawil, Switzerland). The powder was carefully stored
in a cool dry place until further use. Water soluble
extracts were prepared by soaking 50 g of each samples in
hot water (900 ml) and allowed to stand overnight. The
homogenate was filtered using Whatman filter paper
(110 mm, Sigma Aldrich) then freeze dried (FTS systems,
Stone Ridge, NY; USA) to obtain 20 g of crude extracts.
Unless indicated, plant extracts were solubilized in
dimethyl sulfoxide (DMSO) to a stock concentration of
50 mg/ml and stored at 4 °C until required.
Cell cultures
Ethical clearance was obtained from the University of
Venda, Research and Ethics committee. The human
macrophage cell line U937 (ATCC® CRL1593.2), Mewo(ATCC® HTB 65), Vero (ATTC® CCL 81) and the Murine
macrophage RAW 264.7 cells (ATTC® TIB 71) were main-
tained in Roosevelt Park Memorial Institute medium
(RPMI, Sigma Aldrich®; St Louis, MI; USA) or Dubelco’s
modified Eagle Media (DMEM; Sigma Aldrich®; St Louis,
MI; USA) respectively. The media were supplemented
with 10% foetal bovine serum and 0.01% Gentamycin
Sulfate (Sigma Aldrich, St Louis, MI, USA).
Cytotoxicity assay
The method described by Klos et al. [16] was used.
Three cell lines (U923, Mewo and Vero Cells) were used
in this assay. The cells were seeded at a density of 10
000 cells/well (U937) or 6000 cells/well (MeWo/Vero) in
96-well plates (NUNC, Rochester, NY, USA) and incu-
bated for overnight at 37 °C in a humidified 5% CO2
incubator (Thermofisher, Waltham, MA, USA). Samples
were tested in two concentrations, 125 μg/ml and
250 μg/ml for U937cells and 50 μg/ml and 100 μg/ml
for the MeWo/Vero cells for optimal results as obtained
from Prof Van Der Venter’s Lab (Bioassaix, Nelson
Mandela Metropolitan University, PE, South Africa).
After adding the plant samples, the plates were further
incubated for 48 h. Melphalan (Glaxo-smithkline, Paris,
France) was used a positive known toxic chemical.
At the end of the incubation period, the medium was
removed from the adherent plate (MeWo/Vero) and
replaced with fresh DMEM containing methylthiazol
tetrazolium (MTT) at a final concentration of 0.5 mg/ml
[22] and for the suspension plate (U937 cells) 20 μl of
MTT was added per well to also get a final concentra-
tion of 0.5 mg/ml. The plates were again incubated for a
further 3 h to allow reduction of MTT and then the
formed crystals were solubilized by adding DMSO with
gentle shaking for 15 min. Absorbance was read at
560 nm using a multiwall scanning spectrophotometer
(Multiscan MS, Labsystems; Vienna, Virginia, USA). The
percentage of inhibition was calculated as previously
reported by Huda-Faujan et al. [13] as per equation:




RAW 264.7 cells were seeded at a density of 25 000 cells/
wells in a 96-well microtitre plate (NUNC, Rochester, NY,
USA) and allowed to attach overnight. Plant extracts (50
and 100 μg/ml) in complete DMEM medium were added
to replenish the spent culture medium in each well. In
order to stimulate macrophages, 50 μl of lipopolysacchar-
ide (LPS; 10 μg/ml) containing medium was added to
specific wells whereas for unstimulated macrophages,
50 μl of complete medium without LPS was added to the
other wells. A well-known inhibitor of nitric oxide
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Missouri, USA) served as a positive control. To assess the
pro-inflammatory potential. The plates were further incu-
bated for an hour. To quantify the production of nitric
oxide (NO) in both stimulated and non-stimulated cells,
50 μl of the spent culture medium was transferred to new
96 well plates and an equal amount of Griess reagent
(Roche Diagnostics, Risch-Rotkreuz, Switzerland) added.
Absorbance was measured at 510 nm and results com-
pared to the respective controls. Cell viability was also
assessed using the MTT assay to rule out toxicity as a
contributory factor to NO production.
Anti-microbiological activities
This section describes the following tests done: Anti-
bacterial, anti-mycobacterial and anti-HIV activities.
Anti-bacterial activity
There are numerous established methods for the
screening of biological extracts for potential antimicro-
bial activity [9, 28]. For this study, The Eloff [9] method
was used.
Five clinical strains Enterococcus faecalis, Escherichia
coli, Klebsellia Pneumoniae, Salmonella enterica and
Streptococcus agalactiae were grown in Mueller-Hinton
(MH) broth while the media for S. agalactiae was supple-
mented with 10% horse serum. The strains were inocu-
lated in the MH broth (20 ml) and allowed to grow
overnight for 16 h in an orbital incubator (EcoTherm,
Hartkirchen, Austria) 37 °C. Gentamicin sulfate (2 mg/ml;
Sigma Aldrich) and vancomycin hydrochloride (2 mg/ml;
Sigma Aldrich) were used against both Gram negative and
Gram positive bacteria respectively for controls. Due to
Salmonella resistance to gentamicin sulfate, imipinem
dehydrate, penicillin G, chloramphenicol and ampicillin
were tested as additional antibiotics.
The two plant extracts were dissolved in DMSO at a
stock concentration of 50 mg/ml. From the stock solutions,
a working concentration (4 mg/ml) was prepared in MH
broth and filter sterilized (Merck, Darmstadt, Germany).
The experiment was carried out as previously described by
Eloff [9].
Anti-mycobacterial activity
The Mycobacterium tuberculosis H37 strain was ob-
tained from the National Health Laboratory services
(NHLS; Port Elizabeth; South Africa) and was grown in
a culture broth containing DifcoTM Middlebrook 7H9
broth (Difco, Franklin Lakes, NJ; USA), glycerol (Sigma
Aldrich; St Louis, MI, USA), Tween®80 (Sigma Aldrich,
St Louis, MI; USA) and Middlebrook albumin-dextrose-
catalase growth supplement (Sigma) at 37 °C for 10 d.
Rifampicin (1 mg/ml) and ethambutol dihydrochloride
(2 mg/ml) were dissolved at stock concentration of1 mg/ml and 2 mg/ml respectively; and served as posi-
tive controls. The working concentrations obtained were
16 μg/ml and 1 mg/ml prepared in culture broth without
Tween®80 and then filter sterilized (Merck, Darmstadt,
Germany). The plant extracts were dissolved at working
concentrations of 4 mg/ml prepared in culture broth
without Tween®80. The assay was performed as de-
scribed by Franzblau et al. [11] with slight modifications.
Reverse transcriptase inhibition
Reverse transcriptase enzyme is a potential therapeutic
target against retrovirus infection since it plays a vital
role in the conversion of viral ribonucleic acid (RNA) to
complementary deoxyribonucleic acid (cDNA) [3]. The
assay is based on the incorporation of dioxigenin and
biotin labelled nucleotides into the new DNA synthesis.
A commercially available kit was used and the assay was
conducted as per the manufacturer’s instructions (Roche
Diagnostics; Risch-Rotkreuz, Switzerland).
Statistical analyses
All data were captured in Microsoft® Excel spreadsheets
(Office XP, 2010), where descriptive statistics such as the
average, standard deviation, and coefficient of variance
were preformed and for generating graphs. Student t-test
was used for comparison of results obtained for Ziziphus
mucronata and Pterocarpus angolensis Differences in the
data were considered significant when P < 0.05.
Results
Cytotoxicity assay
The results of cytotoxicity assays are shown in Fig. 1.
Cytotoxicity was more pronounced in the U937 cells (A)
than in the MeWo (B) and Vero cells (C). Pterocarpus
angolensis was more cytotoxic than Ziziphus mucronata
in the Vero and MeWo cells, however this was not ap-
parent in the U937 cells. Together these results suggest
some degree of selectivity towards U937 cells.
Anti-Inflammatory activity
Figure 2 illustrates the degree of inhibition in LPS stimu-
lated nitric oxide production (A). It can be seen that
neither of the two samples could reduce nitrate levels
below the untreated LPS-stimulated cells. In the absence
of LPS stimulation there was a significant increase in the
production of NO (B).
Anti-bacterial activity
Table 1 shows the effects of plant extracts on bacterial
growth results of Anti-bacterial. Absorbance readings of
96-well plates were measured at a wavelength of 600 nm
before and after INT addition. Percentage inhibition for the
plant extracts was not calculated as there was no
observable inhibition of microbial growth. Minimal
ab
c
Fig. 1 Cytotoxicity assessment of aqueous extracts of Z. mucronata
and P. angolensis in three cell lines namely Cytotoxicity U937 (a),




Fig. 2 Effect of plant extracts on the production of nitrate and cell
viability in unstimulated macrophage (a) and in macrophage activation
(b). Aminoguanidine, an inhibitor of iNOS expression serves as positive
control to confirm the functionality of the assay. E.coli LPS, inducer of
iNOS activity, was used to demonstrate macrophage activation capacity
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controls and plant extracts are summarized in Table 1.Anti-mycobacterial activity
The results of the anti-microbial activity of A color change
in CellTiter-Blue® reagent was not clear for the higher plant
extract concentrations, due to the extracts color. Plant
extracts have shown anti-tuberculosis activity at concentra-
tions >500 μg/mL. Positive controls’ and plant extract
MIC values are summarized in Table 2. Ethambutol
dihydrochloride has shown no anti-tuberculosis activity
against the M. tuberculosis H37 strain. This specific
strain of M. tuberculosis might be resistant to etham-
butol dihydrochloride.Reverse transcriptase inhibition
Figure 3 illustrates the results of the two plant extracts
activity on HIV replication. Both extracts revealedinhibition of RT activity (>20%). Pterocarpus angolensis
yielded strongest inhibition at both concentrations tested.
Discussion
For medicinal plants to be useful in clinical applications,
the preparations must be selectively toxic to the targeted
microorganisms or must at least interfere directly with a
particular reaction pathway with minimal toxic effects to
the host cells. The present study was aimed at comparing
the in vitro activities of Z. mucronata and P. angolensis.
Our results demonstrated the selective toxicity effect
of the two plants on cancerous cells. As observed in
Fig. 1, cytotoxicity was more pronounced in U937 (P <
0.005) cells for both extracts seen as a decrease in viabil-
ity. The observation suggests some degree of selectivity
towards the U937 cells, thus it can be concluded that
cytotoxicity of these extracts might be cell specific. The
cytotoxic effects observed also in Mewo cells was also
highly statistically significant (P < 0.005). Z. mucronata
displayed the best inhibition on cancerous cells and
stimulatory effect on normal cells. A study done by
Bessong et al., [4] showed no cytotoxicity effects
observed in Z. mucronata extract at the highest tested
concentration (400 μg/ml) in HeLaP4 cells. Brine shrimp
toxicity/lethality results as observed by McGaw et al.
Table 1 MIC values of antibiotics and aqueous extracts of Z. mucronata and P. angolensis
Microorganism Positive control MIC
(μg/ml)
Z. mucronata P. angolensis
MIC(μg/ml) MIC(μg/ml)
Enterococcus faecalis Vancomycin hydrochloride 2 N/A N/A
Escherichia coli Gentamicin sulfate 8 N/A N/A
Klebsiella pneumonia Gentamicin sulfate 2 N/A N/A
Salmonella enterica Gentamicin sulfate/ imipenem dehydrate/ amicillin/ penicillin G/ chloramphenicol Resistanta N/A N/A
Streptococcus agalactiae Vancomycin hydrochloride 2 N/A N/A
aSalmonella was resistant to gentamicin sulfate (0.25 to 64 μg/ml), imipenem dehydrate, ampicillin, penicillin G and chloramphenicol (0.25 to 125 μg/ml)
N/A Not available
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0.9 mg/ml. P. angolensis hexane leaf extract showed tox-
icity of 3.8 mg/ml with increased toxicity as compared
to Z. mucronata. Previous reports revealed that P.
angolensis extracts possess anti-inflammatory activity
[30]. Z mucronata also exhibited cytotoxic effect on
brine shrimp at a concentration of 90.27 μg/ml [25].
This study has demonstrated firstly that Z. mucronata
and P. angolensis do not inhibit NO production and
secondly they do induce activation of macrophages. Macro-
phages are known to produce an extremely great number
pro-inflammatory signals which can change the functional-
ity of the surrounding cells. These includes production of
nitric oxide which has been implicated in the ability to par-
ticipate in diverse regulatory and cytotoxic action, it plays
major role in mediating the human innate immunity [12].
The production of NO has been previously demonstrated
to be of great importance in the regulation of both acute
and chronic inflammation as well as host defense mecha-
nisms against various pathogens [6, 21], though it might
also induce toxic reactions against host tissues if produced
in higher levels [1, 31]. Our results indicate that the extracts
have pro-inflammatory properties; however, it is necessary
to confirm the absence of endotoxins which might present
a similar effect. The nature of the extracts, in terms of their
polysaccharide content, may also provide an indication as
to their pro-inflammatory potential, as many plant polysac-
charides are known to have immunomodulatory activity. A
study done by Samie et al., [32] showed that the seven com-
pounds isolated from bark of P. angolensis were less toxic
when tested against human cells (HCT-8) with an inhibi-
tory concentration of 175–375 μg/ml.
The two plants tested did not have any activities on
selected clinical bacterial species. The percentage for plantTable 2 MIC values of antibiotics and aqueous extracts of Z. mucron
Microorganism Positive control
Mycobacterium tuberculosis Ethambutol dihydrochloride
Rifampicin
aCould not be determined: M. tuberculosis strain might be resistantextract inhibition was not calculated as there was no
observable microbial growth comparing the test and con-
trol wells. The results observed contradict the findings by
Olajuyigbe and Afolayan [26]. The bacterial isolates (E.
faecalis, E. coli, K. pneumoniae) exhibited varied degree of
susceptibility with zones of inhibition ranging between 17
and 27 ± 1.0 mm, though the difference in results can be
attributed to the extraction solvent they used. A study
report published by Samie et al., [32] showed that ethano-
lic extracted compounds from P. angolensis inhibited
bacterial growth of Staphylococcus aureus with median
inhibitory concentration of 25 μg/ml. The results obtained
in this study are not surprising because previous reports
have shown that certain plant water extracts do not
possess any biological activity [17].
However, the same plant extracts tested against M.
tuberculosis H37 demonstrated strong anti-TB activ-
ities at concentrations >500 μg/ml. Tuberculosis is
regarded as one of the major health problem especially in
developing countries and is listed as a leading cause of
death worldwide. An estimation of about 80% individuals
are diagnosed yearly [7, 8]. Due to increase in multi drug
resistance (MDR) and extensively drug resistance TB
(XDR) strains of M. tuberculosis, the need of discovering
newer anti-mycobacterial agents to eradicate the infec-
tions has increased. A study by Ibekwe et al., [15] showed
that Pterocarpus osun Craib exhibited an MIC value of
1225 μg/ml against strain H37.
Furthermore, Z. mucronata and P. angolensis dis-
played anti-HIV replication activity (from 20 to 60%
inhibition) with the activity of P. angolensis similar to
that of Niverapine at 10 μM. Mulaudzi et al. [23] have
classified four levels of RT enzyme inhibition for medi-
cinal plant extracts; with activities below 20% classified asata and P. angolensis
MIC (μg/ml) Z. mucronata P. angolensis
MIC(μg/ml) MIC(μg/ml)
Not determineda >500 μg/ml >500 μg/ml
0.5
Fig. 3 Reverse transcriptase inhibition by the aqueous extracts of Z.
mucronata and P. angolensis. Nevirapine (10uM) was used as a positive
control
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moderate, and 70–100% high activity. According to this
classification the activity of P. angolensis is considered
moderate and may thus warrant further dose response de-
termination and calculation of an IC50 value. A study
done by Bessong et al., 2005 showed RDDP IC50 (77.5 and
81.5) and RNase H IC50 (>100 and 75) activities of Z.
mucronata for aqueous and methanol respectively; how-
ever the plant extracts were prepared from roots and
leaves.
Natural products have been considered the first form
of treatment in the treatment of human diseases. The
use of such products has been in practice for centuries.
The use of modern medicine has developed over the
years through scientific evaluations and observational
efforts of researchers. However, the basis of its develop-
ment ought to be attributed to traditional medicine and
therapies [27]. Nevertheless, ancient wisdom passed on
from generation to generation will remain the basis of
modern medicine and will forever be considered as one
important source of future medicine and therapeutics.
Conclusions
Results obtained showed that both plants have selective
anti-tumor activities with P. angolensis being toxic to
normal cells at higher concentrations but displayed pro-
found anti-HIV activity compared to Z. mucronata. The
observed toxicity on malignant cell lines is to be investi-
gated further for promising anti-cancer therapy drugs.
The activities observed for the two extracts shows the
importance role they can display in treatment of HIV/
AIDS thus reducing the burden of disease, with the sky
rocketing pandemic of the infections in Sub-saharan
Africa natural interventions are urgently needed to help
alleviate this burden of disease.
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